Skip to main navigation Skip to search Skip to main content

Role of SGLT2 inhibitors in cancer therapy-related cardiac dysfunction (CTRCD) in adults: systematic review and meta-analysis: SGLT2 inhibitors and CTRCD

  • Gustavo Adolfo Vásquez-Tirado
  • , Edinson Dante Meregildo-Rodríguez
  • , Claudia Vanessa Quispe-Castañeda
  • , Wilson Marcial Guzmán-Aguilar
  • , Leslie Jacqueline Liñán-Díaz
  • , Percy Hernán Abanto-Montalván
  • , Víctor Serna-Alarcón
  • , Hugo Alva-Guarniz
  • , Mariano Ortiz-Pizarro
  • , Luis Ángel Rodríguez-Chávez
  • , María Cuadra-Campos

    Research output: Contribution to journalArticlepeer-review

    1 Scopus citations
    Original languageEnglish
    Pages (from-to)1197-1210
    Number of pages14
    JournalNaunyn-Schmiedeberg's Archives of Pharmacology
    Volume399
    Issue number1
    DOIs
    StatePublished - 1 Jan 2026

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'Role of SGLT2 inhibitors in cancer therapy-related cardiac dysfunction (CTRCD) in adults: systematic review and meta-analysis: SGLT2 inhibitors and CTRCD'. Together they form a unique fingerprint.

    Cite this